TLR-2 Activation Induces Regulatory T Cells and Long-Term Suppression of Asthma Manifestations in MiceNawijn, M. C., Motta, A. C., Gras, R., Shirinbak, S., Maazi, H. & van Oosterhout, A. J. M., 5-Feb-2013, In : PLoS ONE. 8, 2, 9 p., e55307.
Research output: Contribution to journal › Article › Academic › peer-review
Asthma is a chronic inflammatory disease of the airways characterized by variable airway obstruction and airway hyperresponsiveness (AHR). The T regulatory (Treg) cell subset is critically important for the regulation of immune responses. Adoptive transfer of Treg cells has been shown to be sufficient for the suppression of airway inflammation in experimental allergic asthma. Intervention strategies aimed at expanding the Treg cell population locally in the airways of sensitized individuals are therefore of high interest as a potential therapeutic treatment for allergic airway disease. Here, we aim to test whether long-term suppression of asthma manifestations can be achieved by locally expanding the Treg cell subset via intranasal administration of a TLR-2 agonist. To model therapeutic intervention aimed at expanding the endogenous Treg population in a sensitized host, we challenged OVA-sensitized mice by OVA inhalation with concomitant intranasal instillation of the TLR-2 agonist Pam3Cys, followed by an additional series of OVA challenges. Pam3Cys treatment induced an acute but transient aggravation of asthma manifestations, followed by a reduction or loss of AHR to methacholine, depending on the time between Pam3Cys treatment and OVA challenges. In addition, Pam3Cys-treatment induced significant reductions of eosinophils and increased numbers of Treg cells in the lung infiltrates. Our data show that, despite having adverse acute effects, TLR2 agonist treatment as a therapeutic intervention induces an expansion of the Treg cell population in the lungs and results in long-term protection against manifestation of allergic asthma upon subsequent allergen provocation. Our data indicate that local expansion of Tregs in allergic airway disease is an interesting therapeutic approach that warrants further investigation.
|Number of pages||9|
|Publication status||Published - 5-Feb-2013|
- TOLL-LIKE RECEPTORS, ALLERGIC AIRWAY INFLAMMATION, DENDRITIC CELLS, IMMUNE REGULATION, EPITHELIAL-CELLS, PROTEIN-KINASE, CUTTING EDGE, C-FOS, RESPONSES, TOLL-LIKE-RECEPTOR-2